PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Recycling of 'chauffeur protein' helps regulate fat production

Discovery could advance treatments for obesity and other disorders

2014-02-11
(Press-News.org) Studying a cycle of protein interactions needed to make fat, Johns Hopkins researchers say they have discovered a biological switch that regulates a protein that causes fatty liver disease in mice. Their findings, they report, may help develop drugs to decrease excessive fat production and its associated conditions in people, including fatty liver disease and diabetes.

A summary of the research appeared online on Jan. 29 in the Journal of Biological Chemistry.

"We've learned how the body finely tunes levels of a protein called SCAP that is required to turn on fat production in cells," says Peter Espenshade, Ph.D., professor of cell biology at the Johns Hopkins University School of Medicine. "We hope this new information will eventually lead to interventions that could help people suffering from obesity-induced fatty liver disease and diabetes."

Espenshade explains that fats, which include cholesterol, are essential to the life of organisms, but too much can sabotage systems that rid the body of toxins and regulate hormones, among other functions. Crucial to the right balance of fats is a family of proteins called sterol regulatory element-binding proteins (SREBPs), which turn on fat-making genes when fat levels in cells are low.

SREBPs are made and embedded in the membrane of the cellular compartment called the endoplasmic reticulum, or ER. To get to the cell's nucleus to turn on genes, the business end of SREBPs has to be clipped away from the membrane. Two different proteins, S1P and S2P, make those clips in sequence. But S1P and S2P live in a different cellular compartment, known as the Golgi.

To safely make the trip to the Golgi, says Espenshade, cells give each SREBP a chauffeur — the protein SCAP — which binds to SREBP before they both make their way to the Golgi. Once there, S1P and S2P free SREBP from the membrane so that it can move to the nucleus.

"We knew lots about this first part of the cycle, but we didn't know what happened to SCAP after it 'dropped off' the SREBP," says Espenshade.

While testing a chemical inhibitor of S1P activity, Espenshade says, he and his team added the chemical to hamster cells and were surprised to find that SCAP disappeared from the cells. That meant that it was either no longer being made or was being broken down somehow, he says.

When they added both the S1P inhibitor and a chemical that prevents SCAP from leaving the ER, SCAP reappeared. This suggested that SCAP was still being made but that the S1P inhibitor was somehow encouraging the destruction of SCAP once SCAP left the safety of home base. Further testing revealed that SCAP was indeed being broken down — in another part of the cell called the lysosome.

Tweaking the components of the cycle again, they engineered cells to keep SREBP in the ER while allowing SCAP to move to the Golgi on its own. This time, even though S1P was blocked, SCAP was no longer broken down by the lysosome, suggesting that what determines the fate of SCAP is the clipping of SREBP by S1P. SCAP can only cycle back to the ER for more rounds of SREBP transport if S1P is able to do its job.

"We don't know what is responsible for freeing SCAP from SREBP, but we now understand that SCAP keeps the cycle going," says Espenshade. "Since SCAP is so central to fat production and all of its consequences, we hope this improved understanding of its activity will help others develop drugs to better regulate the process."

The other author of the report is Wei Shao, Ph.D., of the Johns Hopkins University School of Medicine.

INFORMATION:

This work was supported by grants from the Pancreatic Cancer Action Network (12-60-25-ESPE) and the National Heart, Lung and Blood Institute (HL077588).

On the Web:

Link to article

Espenshade Lab

Related stories:

Primitive yeast yields secrets of human cholesterol and drug metabolism

Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 30 primary health care outpatient sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report.

Media Contacts: Catherine Kolf, 443-287-2251; ckolf@jhmi.edu
Vanessa McMains, 410-502-9410; vmcmain1@jhmi.edu


ELSE PRESS RELEASES FROM THIS DATE:

Long distance signals protect brain from viral infections

2014-02-11
The brain contains a defense system that prevents at least two unrelated viruses—and possibly many more—from invading the brain at large. The research is published online ahead of print in the Journal of Virology. "Our work points to the remarkable ability of the immune system, even within the brain, to protect us against opportunistic viruses," says Anthony van den Pol of Yale University, an author on the study. The research explains a long-standing mystery. The olfactory mucosa in the nose can serve as a conduit for a number of viruses to enter the brain including ...

Mayo Clinic identifies a key cellular pathway in prostate cancer

2014-02-11
ROCHESTER, Minn. — Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor — the cellular component that binds to male hormones. The research team has shown that SPOP, a protein that is most frequently mutated in human prostate cancers, is a key regulator of androgen receptor activity that prevents uncontrolled growth of cells in the prostate and thus helps prevent cancer. The findings appear in the journal Cell Reports. "By ...

Flowing water on Mars appears likely but hard to prove

Flowing water on Mars appears likely but hard to prove
2014-02-11
Martian experts have known since 2011 that mysterious, possibly water-related streaks appear and disappear on the planet's surface. Georgia Institute of Technology Ph.D. candidate Lujendra Ojha discovered them while an undergraduate at the University of Arizona. These features were given the descriptive name of recurring slope lineae (RSL) because of their shape, annual reappearance and occurrence generally on steep slopes such as crater walls. Ojha has been taking a closer look at this phenomenon, searching for minerals that RSL might leave in their wake, to try to understand ...

With their amazing necks, ants don't need 'high hopes' to do heavy lifting

With their amazing necks, ants dont need high hopes to do heavy lifting
2014-02-11
COLUMBUS, Ohio—High hopes may help move a rubber tree plant (as the old song goes), but the real secret to the ant's legendary strength may lie in its tiny neck joint. In the Journal of Biomechanics, researchers report that the neck joint of a common American field ant can withstand pressures up to 5,000 times the ant's weight. "Ants are impressive mechanical systems—astounding, really," said Carlos Castro, assistant professor of mechanical and aerospace engineering at The Ohio State University. "Before we started, we made a somewhat conservative estimate that they ...

Chips that listen to bacteria

Chips that listen to bacteria
2014-02-11
VIDEO: The development of colony biofilms by Pseudomonas aeruginosa is affected by redox-active compounds called phenazines. A phenazine-null mutant forms a hyperwrinkled colony with prominent spokes, while wild-type colonies are more... Click here for more information. New York, NY—February 10, 2014—In a study published today in Nature Communications, a research team led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering, ...

Manga comics may help promote fruit consumption among youth

2014-02-11
AUDIO: May May Leung, Ph.D., R.D., discusses how a recent pilot study in Brooklyn, N.Y., with minority students found that exposure to manga comics (Japanese comic art) promoting fruit intake significantly... Click here for more information. PHILADELPHIA, PA, February 10, 2014 – A recent pilot study in Brooklyn, New York, with minority students found that exposure to Manga comics (Japanese comic art) promoting fruit intake significantly improved healthy snack selection. As ...

Political values influence people's response to health disparities messages

Political values influence peoples response to health disparities messages
2014-02-11
PHILADELPHIA (February 10, 2014) – Policymakers and advocates discussing health disparities in the United States would be wise to consider the political affiliation of their audience, suggests a new study published in the Journal of Health Communication: International Perspectives (2014). "Understanding Public Resistance to Messages about Health Disparities" was written by Sarah E. Gollust, University of Minnesota School of Public Health; and Joseph N. Cappella, Annenberg School for Communication, University of Pennsylvania. The study examines how political ...

TGen study uncovers possible genetic markers in breast cancer that spreads to the brain

2014-02-11
PHOENIX, Ariz. — Feb. 10, 2014 — The Translational Genomics Research Institute (TGen) has uncovered possible genetic origins of breast cancer that spreads to the brain, according to a first-of-its-kind study published in the scientific journal PLOS ONE. The compendium of genetic targets uncovered by TGen now can be used to identify potential new methods of diagnosis and new drug therapies for the estimated 45,000 patients in the U.S. each year whose cancer spreads from the breast to the brain. The 3-year study is significant since these patients currently have few treatments ...

New advance in 3-D printing and tissue engineering technology

2014-02-11
Boston, MA – Researchers at Brigham and Women's Hospital (BWH) and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing. Described in the Jan. 28, 2014, issue of Nature Communications, the research was conducted by Savas Tasoglu, PhD, MS, research fellow in the BWH Division of Renal Medicine, and Utkan Demirci, PhD, MS, associate professor of Medicine in the Division of Biomedical Engineering, part of the BWH Department of Medicine, in collaboration ...

Breast cancer drug fights fungal disease

2014-02-11
Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio®, the online open-access journal of the American Society for Microbiology (ASM.) "This work sets the stage for additional animal studies to see if tamoxifen can be used as a drug in people and will allow us to design new drugs related to tamoxifen that are better antifungals," says Damian Krysan ...

LAST 30 PRESS RELEASES:

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

[Press-News.org] Recycling of 'chauffeur protein' helps regulate fat production
Discovery could advance treatments for obesity and other disorders